Join us for our LIVE On Air with phaware® Zoom Webinar Series
This series of interactive LIVE webinars explores the remarkable evolution of Pulmonary Arterial Hypertension (PAH), from its earliest challenges to today's breakthroughs and the promising future of research and care.
Whether you're a patient, caregiver, healthcare professional, researcher, or advocate, these LIVE conversations offer valuable insight into how far the PH community has come and where it's headed next.
Thank you to our webinar sponsors: Merck and Liquidia.
Register for each Webinar separately below.
The early days of PH: Consensus on the target
WED Jul 22 1pM PT | 4PM ET
Sharon I. S. Rounds, MD, ATSF shares a powerful historical perspective on the early days of PH, reflecting on a time when clinicians faced devastating diagnoses with little more than compassion and hope. Discover how those early experiences helped shape decades of innovation, advocacy, and life-changing advances in PAH treatment. REGISTER NOW
THE BIRTH OF MODERN PAH THERAPY
WED AUG 5 9AM PT | 12PM ET
Vallerie V. McLaughlin, MD explores the remarkable story behind prostacyclin, the first successfully targeted pathway for the treatment of pulmonary arterial hypertension (PAH) and its pivotal role in landmark clinical trials, and how the prostacyclin pathway has remained central as treatment algorithms have evolved. REGISTER NOW
COMBINATION THERAPY: REDEFINING PAH TREATMENT STRATEGIES
MON AUG 17 10AM PM | 1PM ET
Sandeep Sahay, MD, MSc, FCCP, ATSF explores the evolution of combination therapy—from the era of single-drug treatment to today's personalized strategies that target multiple disease pathways, including the endothelin, nitric oxide, and prostacyclin pathways. REGISTER NOW
THE FUTURE OF PAH: EMERGING TARGETS AND THERAPIES
WED AUG 19 10AM PT | 1PM ET
Stephen Y. Chan, MD, PhD, ATSF examines the next generation of PAH therapies and the scientific breakthroughs redefining what's possible. Learn how basic, translational, and clinical research are converging to identify novel therapeutic targets, accelerate drug development, and shape the future of pulmonary hypertension care.
REGISTER NOW
GLOBAL CENTERS OF EXCELLENCE: COLLABORATION IN CARE
WED AUG 26 9AM PT | 12PM ET
Go inside the world's leading PAH Centers of Excellence and discover how they're transforming patient care. Vinicio de Jesus Perez, MD, explores the vital role Centers of Excellence play in advancing the diagnosis, treatment, and future of pulmonary arterial hypertension (PAH). REGISTER NOW